CLEVELAND - The German-based manufacturer of the popular blood thinner Pradaxa will pay $650 million to approximately 4000 patients to settle injury lawsuits.
Boehringer Ingelheim says it settled the claims to "avoid the distraction and uncertainty of lengthy litigation."
Most patients complaints related to claims the company failed to adequately warn patients about the risk of internal bleeding.
In February, an exclusive NewsChannel5 investigation revealed Pradaxa is the most complained about drug in the United States.
Our research found more complaints were filed with the FDA about Pradaxa than any other prescription drug in both 2011 and 2012.
Since it was approved by the FDA in 2010, Pradaxa has been blamed for 1,158 U.S. deaths and 12,494 serious injuries, according to Tom Moore, the senior scientist for drug safety and policy at the Institute for Safe Medication Practices. The ISMP is a non-profit organization that monitors FDA reports.
Pradaxa is used to treat atrial fibrillation, a heart condition that significantly increases the risk of stroke.
Indictments filed in Jimmy Haslam company probe
Eight former employees of Jimmy Haslam's Pilot Flying J Travel Centers have been indicted for their role in a fuel rebate fraud probe…
Controversial disciplinary methods in OH schools
A new report released Monday by Disability Rights Ohio found the Ohio Department of Education fails to enforce a rule regulating…
How does Ohio's parole system really work?
Ohio's parole system continues to rebuild following significant cutbacks five years ago that left parole officers supervising as many as…
OH schools use dangerous disciplinary methods
An exclusive NewsChannel 5 investigation has uncovered Ohio schools failing to follow rules meant to protect the state’s most…